title: Landmark trials in endocrine adjuvant therapy for breast carcinoma.
abstract: The review summarizes the outcomes of several landmark trials involving aromatase inhibitors that helped formulate current therapeutic approaches recommended by the American Society of Clinical Oncology for breast carcinoma treatment.
authors.affiliation: Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA. w-gradishar@northwestern.edu
authors.forename: William
authors.initials: W
authors.lastname: Gradishar
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D017410:Practice Guidelines as Topic
chemical_list: D018931:Antineoplastic Agents, Hormonal